This suggests an important potential role of IL-17-mediated inflammation in the pathogenesis of CVA, and ZSS might be effective in treating inflammation/asthma by regulating T-cell differentiation especially IL-17 secretion after Th17 activation. The gene discussed is IL17A; the disease is asthma.